SCHEMBL25615224

SCHEMBL25615224

C/C=C1C(=C/C)\c2ccccc2C\1(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.45
MLNR O43193 1/20 0.45
NR1I2 O75469 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRB1 P08588 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
CHRM3 P20309 1/20 0.45
DRD1 P21728 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2C P28335 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
HRH1 P35367 1/20 0.45
OPRM1 P35372 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24432722 0.84 MLNR (0.40) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL26644176 0.84 MLNR (0.40) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL21510742 0.84 MLNR (0.40) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL24609376 0.84 MLNR (0.40) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL26383316 0.82 ESR1 (0.37) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL22136780 0.80 MLNR (0.37) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL25817504 0.80 ESR1 (0.40) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL22373981 0.78 HTR2A (0.44) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL3370471 0.78 PGR (0.41) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL3370477 0.78 PGR (0.41) HTR2AMLNRNR1I2CHRM2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11711973-B2 Organic electronic device DUK SAN NEOLUX CO., LTD. (KR) 2023-07-25 US disclosed
US-11696496-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-04 US disclosed
US-20230200219-A1 A compound, an organic electroluminescent device and a display device BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) 2023-06-22 US disclosed
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 HTR2A 4129/4885MLNR 4833/4885NR1I2 3304/4885
US-20230200219-A1 A compound, an organic electroluminescent device and a display device L1CAM, VDAC2, CD274 HTR2A 22/4885MLNR 3091/4885NR1I2 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.